Table 2 Current status of use of global indicators for the 45 included WHO Essential Interventions
Intervention | Population data (Percent of the population) | Facility data (Number of survey instruments) | ||||||
|---|---|---|---|---|---|---|---|---|
Screening process indicator | Screening outcome indicator | COVERAGE/Management process indicator | Management outcome indicator | Availability of supplies | Staff ever trained | Ever performed at this facility | ||
Preconception/ Periconception and Pregnancy | Folic acid supplementation or fortification | NA | NA | – | – | 5 of 7i | 4 of 7 | 3 of 7 |
Family planninga | – | 22 % | 31 % | 4 % | 5 of 7 | 4 of 7 | 3 of 7 | |
Prevention and management of STIs and HIV | – | – | – | – | 1 of 7 | 2 of 7 | 2 of 7 | |
Safe abortion services | – | – | 26 % | – | 4 of 7 | 2 of 7 | 4 of 7 | |
Post-abortion care | – | – | – | – | 2 of 7 | 2 of 7 | 2 of7 | |
Antenatal care visit (1+) (contact) | NA | NA | 84 % | – | NA | NA | NA | |
Antenatal care visit (4+) (contact) | NA | NA | 57 % | – | NA | NA | NA | |
Essential packageb | NA | NA | – | – | 4 of 7 | 4 of 7 | 3 of 7 | |
Iron and folic acid supplementationc | NA | NA | 26 % | – | 4 of 7 | 2 of 7 | 3 of 7 | |
Tetanus toxoid vaccinationd | NA | NA | 81 % | – | 4 of 7 | 0 of 7 | 3 of 7 | |
Prevention of malaria with prophylactic antimalarials | NA | NA | 27 % | – | 4 of 7 | 4 of 7 | 4 of 7 | |
Prevention of malaria with ITN | NA | NA | 37 % | – | ||||
Smoking cessation during pregnancy | – | – | – | – | 0 of 7 | 0 of 7 | 0 of 7 | |
Detection and management of syphilise | 44 % | 2 % | 37 % | – | 5 of 7 | 5 of 7 | 5 of 7 | |
Detection and management of HIV (including PMTCT)f | – | 3 % | 67 % | 17 % | 6 of 7 | 4 of 7 | 6 of 7 | |
Calcium supplementation for deficient women in pregnancy | – | – | – | – | 1 of 7 | 0 of 7 | 0 of 7 | |
Aspirin for pre-eclampsia prevention | – | – | 1 of 7 | 0 of 7 | 0 of 7 | |||
Antihypertensive drugs for hypertension in pregnancy | – | – | 3 of 7 | 0 of 7 | 1 of 7 | |||
Anticonvulsants (i.e., MgSO4) | – | – | – | – | 7 of 7 | 2 of 7 | 3 of 7 | |
External cephalic version | – | – | – | – | 0 of 7 | 0 of 7 | 0 of 7 | |
Induction of labor after pPRoM | – | – | – | – | 0 of 7 | 0 of 7 | 1 of 7 | |
Antibiotics for pPRoM | – | – | – | – | 6 of 7 | 0 of 7 | 3 of 7 | |
Antenatal corticosteroids | – | – | – | – | 4 of 7 | 0 of 7 | 1 of 7 | |
Childbirth and postpartum care | Skilled attendant at birth (contact) | NA | NA | 66 % | – | NA | NA | NA |
Facility delivery (contact) | NA | NA | 63 % | – | NA | NA | NA | |
Social support during childbirth | NA | NA | – | – | 0 of 7 | 0 of 7 | 0 of 7 | |
Prophylactic antibiotics for cesarean section | – | – | – | – | 5 of 7 | 1 of 7 | 3 of 7 | |
Cesarean section | – | – | 10 % | – | 3 of 7 | 2 of 7 | 4 of 7 | |
Uterotonics for prevention of hemorrhage | NA | NA | – | – | 8 of 8 | 5 of 8 | 6 of 8 | |
Active management of the 3rd stage of labor | NA | NA | – | – | 8 of 8 | 5 of 8 | 4 of 8 | |
Induction at ≥ 41 weeks of gestation | – | – | – | – | 0 of 7 | 0 of 7 | 1 of 7 | |
Uterotonics for treatment of hemorrhage | – | – | – | – | 8 of 8 | 2 of 8 | 5 of 8 | |
Manual removal of the placenta | – | – | – | – | 4 of 7 | 2 of 7 | 3 of 7 | |
Initiation or continuation of HIV therapy for HIV positive women f (see above) α | – | 3 % | 67 % | 17 % | 6 of 7 | 4 of 7 | 6 of 7 | |
Family planning and advice for contraceptives a (See above) α | – | 22 % | 31 % | 4.00 % | 5 of 7 | 4 of 7 | 3 of 7 | |
Screen for and initiate or continue antiretroviral therapy for HIV f (see above) α | – | 3 % | 67 % | 17 % | 6 of 7 | 4 of 7 | 6 of 7 | |
Treat maternal anemiag | – | 40 % | – | – | 0 of 7 | 0 of 7 | 0 of 7 | |
Detect and manage postpartum sepsis | – | – | – | – | 0 of 7 | 1 of 7 | 1 of 7 | |
Newborns and small and ill babies | Immediate thermal care | – | – | – | – | 4 of 7 | 3 of 7 | 2 of 7 |
Promotion and support for early Initiation of breastfeeding | NA | NA | 50 % | – | 1 of 7 | 4 of 7 | 3 of 7 | |
Promotion and provision of hygienic cord and skin care | NA | NA | – | – | 1 of 7 | 2 of 7 | 2 of 7 | |
Neonatal resuscitation | – | – | – | – | 6 of 7 | 3 of 7 | 6 of 7 | |
Newborn Immunizationh | NA | NA | 91 %/37 % | – | 2 of 7 | 0 of 7 | 1 of 7 | |
Presumptive antibiotic therapy for newborns at risk of bacterial infection | – | – | – | – | 2 of 7 | 1 of 7 | 2 of 7 | |
Case management of neonatal sepsis, meningitis, and pneumonia | – | – | – | – | 2 of 7 | 1 of 7 | 2 of 7 | |
Initiation of ART in babies born to HIV infected mother f (see above) α | – | 3 % | 67 % | 17 % | 6 of 7 | 4 of 7 | 6 of 7 | |
Kangaroo mother care for preterm and for <2000 g babies | – | – | – | – | 1 of 7 | 1 of 7 | 1 of 7 | |
Extra support for feeding the small and preterm baby | – | – | – | – | 0 of 7 | 0 of 7 | 1 of 7 | |
Prophylactic and therapeutic use of surfactant | – | – | – | – | 0 of 7 | 0 of 7 | 1 of 7 | |
Continuous positive airway pressure (CPAP) for RDS | – | – | – | – | 0 of 7 | 0 of 7 | 1 of 7 | |
Management of newborns with Jaundice | – | – | – | – | 1 of 7 | 0 of 7 | 1 of 7 | |